NCT03304080 2025-07-18Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastIcahn School of Medicine at Mount SinaiPhase 1/2 Active not recruiting44 enrolled